A XM não fornece serviços a residentes nos Estados Unidos da América.

Wall St loses ground as chip, oil stocks plummet



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall St loses ground as chip, oil stocks plummet</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Nvidia falls from record high

UnitedHealth down after Q3 results

Banks broadly gain after earnings

Indexes down: Dow 0.39%, S&P 500 0.44%, Nasdaq 0.93%

Updated at 11:55 ET/1555 GMT

By Lisa Pauline Mattackal and Purvi Agarwal

Oct 15 (Reuters) - Wall Street slipped on Tuesday, with the tech-heavy Nasdaq leading the decline, as a slump in semiconductor and oil stocks offset strong quarterly results from major banks.

Nvidia NVDA.O tumbled 5.6% followinga record high close on Monday, after a report the Biden administration is considering capping AI-chip exports by U.S. companies.

Chip stocks lost more ground after results of chip-equipment-maker ASML Holdings ASML.AS, published early in an apparent error, showed the company was downbeat on its 2025 sales. ASML's U.S.-listing ASML.O dropped 17%, while an index of chip stocks .SOX fell 4.6%.

Energy stocks .SPNY fell 2.2%, as crude prices fell due to a weaker demand outlook and after a media report suggested Israel would not strike Iranian oil targets O/R.

The declines offset broadly positive results from major banks, as Bank of America BAC.N jumped 2% following a third-quarter profit beat, while Charles Schwab SCHW.N soared 8.3% after beating estimates.

The broader Banks index .SPXBK rose 1.3% and was trading at its highest level in more than two years, while an index of regional banks .KRX gained 2.4%.

Meanwhile, the blue-chip Dow opened at a record high but fell quickly, weighed down by a 7.3% slump in healthinsurer UnitedHealth UNH.N after the company forecast 2025 profit below Wall Street estimates.

"There's a lot of indecision today, with Nvidia and some of the higher flyers seeing more weakness," said Ryan Detrick, chief market strategist at the Carson Group.

Detrick said investors were likely also booking some profits after a thin trading session on Monday, when bond markets were closed for a holiday, as they looked ahead to key economic data and a continued deluge of earnings over the next few weeks.

Both the Dow and the S&P 500 closed at record highs on Monday.

TheDow Jones Industrial Average .DJI fell 169.70 points, or 0.39%, to 42,895.52, the S&P 500 .SPX lost 25.99 points, or 0.44%, to 5,833.86, and the Nasdaq Composite .IXIC lost 173.96 points, or 0.93%, to 18,329.97.

Bucking the decline in tech stocks, Apple AAPL.O rose 1.8% to touch a record high.

A number of S&P 500 companies are scheduled to report results through the week. The large ones will need to justify their expensive stock valuations to investors, particularly in the tech sector, where valuations have grown increasingly inflated in the past year.

Key economic data, including monthly retail sales and industrial production figures, are due this week, while Federal Reserve officials Adriana Kugler and Raphael Bostic are expected to speak on the day.

San Francisco Fed President Mary Daly said that even after September's interest-rate cut, policymakers were still working to bring inflationary pressures down.

Traders are pricing in about an 88% chance the Fed will cut interest rates by 25 basis points in November, according to CME's FedWatch.

Walgreens Boots Alliance WBA.O soared 11.9% after narrowly beating Wall Street's lowered estimates for fourth-quarter adjusted profit.

Advancing issues outnumbered decliners by a 1.51-to-1 ratio on the NYSE, and by a 1.19-to-1 ratio on the Nasdaq.

The S&P 500 posted 110 new 52-week highs and no new lows, while the Nasdaq Composite recorded 138 new highs and 50 new lows.



Reporting by Lisa Mattackal and Purvi Agarwal in Bengaluru; Editing by Pooja Desai

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.